<?xml version="1.0" encoding="UTF-8"?>
<ref id="B85-pharmaceuticals-12-00060">
 <label>85.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shiryaev</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Mesci</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Pinto</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Fernandes</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Sheets</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Shresta</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Farhy</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>C.-T.</given-names>
   </name>
   <name>
    <surname>Strongin</surname>
    <given-names>A.Y.</given-names>
   </name>
   <name>
    <surname>Muotri</surname>
    <given-names>A.R.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis</article-title>
  <source>Sci. Rep.</source>
  <year>2017</year>
  <volume>7</volume>
  <fpage>15771</fpage>
  <pub-id pub-id-type="doi">10.1038/s41598-017-15467-6</pub-id>
  <pub-id pub-id-type="pmid">29150641</pub-id>
 </element-citation>
</ref>
